ESG Rating And Honors

August 2024 SynTao Green Finance ESG Rating for the second quarter of 2024: A-
August 2024 The 21st Century Vitality · ESG Corporate Governance Cases
July 2024 MSCI ESG Ratings: AAA (The first and only Chinese company in the global pharmaceutical industry to receive the highest MSCI ESG AAA rating, and the only company in the Chinese pharmaceutical industry to do so for two consecutive years)
July 2024 2024 ESG Model Enterprise Award and 2024 ESG Outstanding Case Award at the Third International Green Zero-Carbon Festival
July 2024 Included in the "Sustainability Yearbook 2024 (China Edition)" by S&P Global and recognized as Industry Mover
July 2024 2024 Yinghua Awards for Chinese Listed Companies: Hong Kong Stock ESG Value Award
June 2024 Wind ESG Rating: AA (Ranked second among domestic pharmaceutical peers as of now)
April 2024 Sino-Securities ESG Rating: A
February 2024 CDP Climate Change Questionnaire: B
February 2024 Included in the "Sustainability Yearbook 2024" by S&P Global and recognized as Industry Mover
January 2024 Included in 2023 Easy-board ESG+8 Top 100 List
January 2024 Best ESG Award (Roadshow China & Excellence IR)
December 2023 The Sina Finance China ESG "Golden Awards" 2023 Excellent Enterprise for Environmental Responsibility
December 2023 The Sina Finance 2023 Pharmaceutical Industry Golden Kirin Award - the Most Socially Responsible Pharmaceutical Company
December 2023 2023 TOP 50 ESG Listed Companies in China’s Non-Financial Industry (China Corporate Governance Experts 50 Forum)
December 2023 Top 100 Wind Chinese Listed Companies in Best ESG Practice in 2023
November 2023 S&P Global ESG Score: 65 (Ranked among the top 5% of global participating pharmaceutical companies)
October 2023 CNI ESG Ratings: AAA (Ranked first among domestic pharmaceutical industry)

October 2023 The Top 20 Chinese Pharmaceutical Listed Companies in ESG Competitiveness in 2023 (Mid-cap Stocks)
August 2023 Top1 of CSR Survey Score of Pharmaceutical Enterprises of Southern Weekly in 2022
August 2023 CSI ESG Rating: AAA
July 2023 MSCI ESG Ratings: AAA (The first and only Chinese company in the global pharmaceutical industry to receive the highest MSCI ESG AAA rating)
May 2023 Wind ESG Rating: AA (Ranked first among domestic pharmaceutical peers as at June 2024)
May 2023 5th New Fortune Best Listed Company — Best ESG Practice Award
December 2022 CDP Climate Change Questionnaire: B-
December 2022 The Reputation List of China Listed Companies for 2022 — Most Socially Responsible Listed Company
December 2022 6th China IR Annual Awards — Best ESG Award
November 2022 S&P Global CSA Score: 42
November 2022 Top 1 of the Top 20 Chinese Pharmaceutical Listed Companies in ESG Competitiveness in 2022
October 2022 Top 10 Wind Chinese Hong Kong-listed Companies in ESG Ratings in 2022 — Healthcare Industry
September 2022 Top 10 Wind Chinese A-shares Listed Companies in ESG Ratings in 2022 — Healthcare Industry
March 2022 New Fortune — Best ESG Information Disclosure Award

Add: No.38, Chuangye North Road, Jinwan District, Zhuhai, Guangdong, P.R.China Tel： 0756-8135888

Home | E-Mail | Legal Declaration

Add: No.38, Chuangye North Road, Jinwan District, Zhuhai, Guangdong, P.R.China

Support：300.cn